JP2024524270A5 - - Google Patents
Info
- Publication number
- JP2024524270A5 JP2024524270A5 JP2023579317A JP2023579317A JP2024524270A5 JP 2024524270 A5 JP2024524270 A5 JP 2024524270A5 JP 2023579317 A JP2023579317 A JP 2023579317A JP 2023579317 A JP2023579317 A JP 2023579317A JP 2024524270 A5 JP2024524270 A5 JP 2024524270A5
- Authority
- JP
- Japan
- Prior art keywords
- muscle
- sequence
- vector
- promoter
- expression cassette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2108997.4 | 2021-06-23 | ||
| GBGB2108997.4A GB202108997D0 (en) | 2021-06-23 | 2021-06-23 | Regulatory nucleic acid sequences |
| GB2111317.0 | 2021-08-05 | ||
| GB202111317 | 2021-08-05 | ||
| PCT/GB2022/051611 WO2022269269A1 (en) | 2021-06-23 | 2022-06-23 | Regulatory nucleic acid sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524270A JP2024524270A (ja) | 2024-07-05 |
| JP2024524270A5 true JP2024524270A5 (enExample) | 2025-07-02 |
Family
ID=82655313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579317A Pending JP2024524270A (ja) | 2021-06-23 | 2022-06-23 | 調節性核酸配列 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250129381A1 (enExample) |
| EP (1) | EP4359548A1 (enExample) |
| JP (1) | JP2024524270A (enExample) |
| KR (1) | KR20240023643A (enExample) |
| AU (1) | AU2022297795A1 (enExample) |
| CA (1) | CA3221707A1 (enExample) |
| IL (1) | IL309630A (enExample) |
| WO (1) | WO2022269269A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202319008D0 (en) * | 2023-12-13 | 2024-01-24 | Ucl Business Ltd | AAV-mediated gene therapy of diseases caused by impaired function of GLDC |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| US6221349B1 (en) | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
| US8106180B2 (en) | 2003-08-07 | 2012-01-31 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro RNAs |
| US20050142581A1 (en) | 2003-09-04 | 2005-06-30 | Griffey Richard H. | Microrna as ligands and target molecules |
| WO2005056761A2 (en) | 2003-12-05 | 2005-06-23 | Massachusetts Institute Of Technology | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| KR100614827B1 (ko) | 2004-05-06 | 2006-08-25 | 재단법인서울대학교산학협력재단 | 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체 |
| AU2015208247B2 (en) * | 2014-01-21 | 2021-05-27 | Universiteit Gent | Muscle-specific nucleic acid regulatory elements and methods and use thereof |
| AU2020392243A1 (en) * | 2019-11-28 | 2022-06-16 | Regenxbio Inc. | Microdystrophin gene therapy constructs and uses thereof |
| EP4081643A1 (en) * | 2019-12-24 | 2022-11-02 | Asklepios Biopharmaceutical, Inc. | Regulatory nucleic acid sequences |
| CN116406297A (zh) * | 2020-08-05 | 2023-07-07 | 阿斯克肋匹奥生物制药公司 | 治疗心脏疾患和充血性心力衰竭以及施用aav载体的方法 |
| US20230374542A1 (en) * | 2020-10-07 | 2023-11-23 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21) |
-
2022
- 2022-06-23 CA CA3221707A patent/CA3221707A1/en active Pending
- 2022-06-23 JP JP2023579317A patent/JP2024524270A/ja active Pending
- 2022-06-23 US US18/572,668 patent/US20250129381A1/en active Pending
- 2022-06-23 WO PCT/GB2022/051611 patent/WO2022269269A1/en not_active Ceased
- 2022-06-23 KR KR1020247002456A patent/KR20240023643A/ko active Pending
- 2022-06-23 IL IL309630A patent/IL309630A/en unknown
- 2022-06-23 AU AU2022297795A patent/AU2022297795A1/en active Pending
- 2022-06-23 EP EP22744500.4A patent/EP4359548A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bostick et al. | Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice | |
| JP7415042B2 (ja) | プラコフィリン２遺伝子治療の方法および組成物 | |
| KR102584655B1 (ko) | 조절성 폴리뉴클레오티드 | |
| JP7418826B2 (ja) | 不整脈源性右心室心筋症における電気的機能及び心臓機能並びに心構造を回復するための遺伝子療法戦略 | |
| JP2020503869A (ja) | トリプルガイド配列と共にｃｒｉｓｐｒ／ｃａｓ９を用いるエクソンスキッピング改変のための最適化戦略 | |
| JP2006524691A (ja) | 心臓導電系の標的化された領域の遺伝子修飾 | |
| US11781156B2 (en) | Plakophillin-2 gene therapy methods and compositions | |
| JP2023509118A5 (enExample) | ||
| CN113730388A (zh) | 辛酸钠在制备改善心肺复苏效果以及心肺复苏后多器官功能障碍的药物中的应用 | |
| JP2023525476A5 (enExample) | ||
| Southall et al. | Imipramine poisoning: survival of a child after prolonged cardiac massage | |
| TW202400798A (zh) | 斑菲素蛋白—２（ｐｌａｋｏｐｈｉｌｌｉｎ—２）基因療法之治療方法 | |
| CN108888753B (zh) | 酸性糖蛋白orm在制备治疗心力衰竭药物中的应用 | |
| CN115287276A (zh) | Sem1蛋白、表达sem1蛋白工程化益生菌在制备治疗和/或预防心脏病药物中的应用 | |
| Wittlieb-Weber et al. | A novel GJA1 mutation causing familial oculodentodigital dysplasia with dilated cardiomyopathy and arrhythmia | |
| Kaur et al. | Extreme hyperthermia-induced arrhythmogenesis | |
| JP2023540545A5 (enExample) | ||
| CN117378563B (zh) | 一种肺动脉高压动物模型的构建方法及其应用 | |
| US20250360171A1 (en) | Chemogenetically gated ion channels and use thereof | |
| Bin et al. | Effects of remote ischemic preconditioning on early myocardial post-infarction remodeling | |
| Ellesøe et al. | Normalisation of left ventricular systolic function after change from VVI pacing to biventricular pacing in a child with congenital complete atrioventricular block, long-QT syndrome, and congenital muscular dystrophy: a 10-year follow-up | |
| Salvini et al. | Myocarditis Associated with Coronavirus Disease 2019 (COVID-19) in a Pediatric Patient | |
| WO2024125494A1 (zh) | 一种基因调节的方法及其应用 | |
| Molvin et al. | 5211 Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort | |
| Kim et al. | Pathological substratum for a case of fulminant myocarditis treated with extracorporeal membrane oxygenation and subsequent heart transplantation |